Home > Resources > Whitepapers > Validation of ICON™ Automated Cell Counting and Viability Assay

Cell and Gene Therapy

Validation of ICON™ Automated Cell Counting and Viability Assay

August 10, 2022

Validation of ICON

Determination of cell viability and concentration using trypan blue exclusion is essential for biotherapeutic workflows,
enabling optimisation of protocols, monitoring of changes to the culture environment, and selection of the best clones
for culture progression.

Spotlight

Acris Antibodies

Acris GmbH was founded 1998 as a spinoff of DPC Biermann GmbH, the German subsidiary of Diagnostic Products Corp., Los Angeles. Acris took over responsibility for marketing the DPC Biermann research products, mostly antibodies. From the very beginning it was our mission to serve the research community with high quality research products. It was our strategy to develop a platform for thousands of high quality antibodies in one easy to search online database.

OTHER WHITEPAPERS

Transforming cell & gene therapy manufacturing

whitePaper | February 25, 2022

Digitalization and automation promise a better way to streamline the transfer of cell and gene therapies from drug discovery – to commercial production.

Read More

Bioanalytical Techniques to Advance Biosimilars Development

whitePaper | August 22, 2022

Biosimilar therapies offer more unique approaches to treating patients with serious diseases, such as cancer.

Read More

Improve Your Gene-Editing Success With CRISPR-SNIPER Technology

whitePaper | February 15, 2023

The discovery of both CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated proteins, the Cas nucleases, has revolutionized the field of gene-editing.

Read More

Risk assessment of fungal materials

whitePaper | February 24, 2022

Sustainable fungal materials have a high potential to replace non-sustainable materials such as those used for packaging or as an alternative for leather and textile.

Read More

Growing a circular economy with fungal biotechnology

whitePaper | August 17, 2022

Fungi have the ability to transform organic materials into a rich and diverse set of useful products and provide distinct opportunities for tackling the urgent challenges before all humans.

Read More

The US Bioeconomy

whitePaper | April 14, 2022

In the nearly 50 years since the first genetic engineering experiments, the United States has become the world’s biotechnology powerhouse,

Read More

Transforming cell & gene therapy manufacturing

whitePaper | February 25, 2022

Digitalization and automation promise a better way to streamline the transfer of cell and gene therapies from drug discovery – to commercial production.

Read More

Bioanalytical Techniques to Advance Biosimilars Development

whitePaper | August 22, 2022

Biosimilar therapies offer more unique approaches to treating patients with serious diseases, such as cancer.

Read More

Improve Your Gene-Editing Success With CRISPR-SNIPER Technology

whitePaper | February 15, 2023

The discovery of both CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated proteins, the Cas nucleases, has revolutionized the field of gene-editing.

Read More

Risk assessment of fungal materials

whitePaper | February 24, 2022

Sustainable fungal materials have a high potential to replace non-sustainable materials such as those used for packaging or as an alternative for leather and textile.

Read More

Growing a circular economy with fungal biotechnology

whitePaper | August 17, 2022

Fungi have the ability to transform organic materials into a rich and diverse set of useful products and provide distinct
opportunities for tackling the urgent challenges before all humans.

Read More

The US Bioeconomy

whitePaper | April 14, 2022

In the nearly 50 years since the first genetic engineering experiments, the United States has become the world’s biotechnology powerhouse,

Read More

More Whitepapers

Spotlight

Acris Antibodies

Acris GmbH was founded 1998 as a spinoff of DPC Biermann GmbH, the German subsidiary of Diagnostic Products Corp., Los Angeles. Acris took over responsibility for marketing the DPC Biermann research products, mostly antibodies. From the very beginning it was our mission to serve the research community with high quality research products. It was our strategy to develop a platform for thousands of high quality antibodies in one easy to search online database.

Events

8th International Conference on Bio-Sensing Technology

Conference

8th International Conference on Bio-Sensing Technology

Conference